An expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a new study.

The disease? It's genital warts, a sexually-transmitted problem that is embarrassing and uncomfortable but not life-threatening.

Still, the results are expected to bolster a likely bid by the vaccine's manufacturer — Merck & Co. Inc. — to begin marketing the vaccine to boys, experts said. Merck plans to ask the government for that approval later this year.

This is an obvious and reprehensible attempt to sell more of their ineffective and potentially dangerous Gardasil vaccine. Once you carefully study the evidence you will understand that the boys who receive the proposed Gardasil vaccine will begin to experience side effects, just as their female peers did.